Comparison of Early Pregnancy Loss Management Between States With Restrictive and Supportive Abortion Policies

Tal, Elana; Paul, Rachel; Dorsey, Megan; Madden, Tessa

doi:10.1016/j.whi.2022.10.001

Cited by 12 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our inquiry was conducted in Massachusetts and may not reflect opinions or experiences of obstetrician‐gynecologists in other regions where practice norms and cultures differ. A convenience sample survey of 350 obstetrician‐gynecologists in academic practice in the US revealed no difference in likelihood of using mifepristone or office uterine aspiration for EPL in respondents in states hostile to or supportive of abortion after controlling for perceived institutional support and prior abortion training, suggesting that findings among our study population may also be relevant to obstetrician‐gynecologists in states with different reproductive health policies 28 . Still, understanding the Massachusetts abortion policy landscape helps to contextualize our findings.…”

Section: Discussionmentioning

confidence: 71%

Mifepristone use for early pregnancy loss: A qualitative study of barriers and facilitators among OB/GYNS in Massachusetts, USA

Neill

Mokashi

Goldberg

et al. 2023

Perspect Sexual Reproductive

View full text Add to dashboard Cite

ContextEarly pregnancy loss (EPL) affects 1 million patients in the United States (US) annually, but integration of mifepristone into EPL care may be complicated by regulatory barriers, practice‐related factors, and abortion stigma.MethodsWe conducted qualitative, semi‐structured interviews among obstetrician‐gynecologists in independent practice in Massachusetts, US on mifepristone use for EPL. We recruited participants via professional networks and purposively sampled for mifepristone use, practice type, time in practice, and geographic location within Massachusetts until we reached thematic saturation. We analyzed interviews using inductive and deductive coding under a thematic analysis framework to identify facilitators of and barriers to mifepristone use.ResultsWe interviewed 19 obstetrician‐gynecologists; 12 had used mifepristone for EPL and 7 had not. Participants were in private practice (n = 12), academic practice (n = 6), or worked at a federally qualified health center (n = 1). Seven had fellowship training, including four in complex family planning. The most common facilitators of mifepristone use for EPL were access to the expertise or protocols of local‐regional experts, leadership from a “champion,” prior experience with abortion care, and hospital capacity constraints during the COVID‐19 pandemic. The most common barriers were related to the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) Program imposed by the US Food and Drug Administration (FDA). Additionally, mifepristone's affiliation with abortion was a barrier to its use in EPL for some obstetrician‐gynecologists.ConclusionThe FDA Mifepristone REMS Program presents substantial barriers to obstetrician‐gynecologists incorporating mifepristone into their EPL care.

show abstract

Section: Discussionmentioning

confidence: 71%

Mifepristone use for early pregnancy loss: A qualitative study of barriers and facilitators among OB/GYNS in Massachusetts, USA

Neill

Mokashi

Goldberg

et al. 2023

Perspect Sexual Reproductive

View full text Add to dashboard Cite

show abstract

“…10 As with methotrexate and misoprostol, this represents an off-label use of these medications, which has created uncertainty about using them for miscarriage management as states have begun enforcement of antiabortion legislation that would limit their use. 11…”

Section: Medication Management Regimensmentioning

confidence: 99%

Mifepristone and misoprostol in the management of early pregnancy loss

Levi¹

2023

WHC

View full text Add to dashboard Cite

show abstract

“…I was fortunate enough to live in Colorado, where access to these types of medications remains legal. But infringements on reproductive rights, also threaten access to reproductive care that is "legal, safe, and free" for people experiencing reproductive loss, particularly for birthing persons of color (Tal et al, 2023).…”

Section: Dwelling In Reproductive Lossmentioning

confidence: 99%

“An act of compassion”: Emotion and the struggle for reproductive justice

Torres

2023

Feminist Anthropology

View full text Add to dashboard Cite

In dialogue with the rich scholarship on affect and the role of emotions in feminist knowledge production, this article explores how compassion is mobilized by activists in the struggle for reproductive justice. The author centers emotional knowledge by drawing on conversations with a reproductive justice advocate in central Florida, the musical anthem of Viva Ruíz and the Thank God for Abortion Collective, and her own personal experience with pregnancy loss. This includes a discussion of the ways that coloniality persists in the racialized and gendered landscape of reproductive politics, with particular attention to the experiences of Puerto Ricans. Ultimately, the article argues that an attunement to “a radical compassion”—that is, a deep concern and understanding of the intersectional oppressions that place value on certain bodies over others—engenders the possibilities of reproductive justice and produces alternative ways of knowing and feeling.

show abstract

Comparison of Early Pregnancy Loss Management Between States With Restrictive and Supportive Abortion Policies

Cited by 12 publications

References 20 publications

Mifepristone use for early pregnancy loss: A qualitative study of barriers and facilitators among OB/GYNS in Massachusetts, USA

Mifepristone use for early pregnancy loss: A qualitative study of barriers and facilitators among OB/GYNS in Massachusetts, USA

Mifepristone and misoprostol in the management of early pregnancy loss

“An act of compassion”: Emotion and the struggle for reproductive justice

Contact Info

Product

Resources

About